Xtant Medical Hldgs Stock Fundamentals
| XMS Stock | EUR 0.34 0.01 3.03% |
XTANT MEDICAL HLDGS fundamentals help investors to digest information that contributes to XTANT MEDICAL's financial success or failures. It also enables traders to predict the movement of XTANT Stock. The fundamental analysis module provides a way to measure XTANT MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to XTANT MEDICAL stock.
XTANT |
XTANT MEDICAL HLDGS Company Shares Owned By Insiders Analysis
XTANT MEDICAL's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current XTANT MEDICAL Shares Owned By Insiders | 7.59 % |
Most of XTANT MEDICAL's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XTANT MEDICAL HLDGS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 7.59% of XTANT MEDICAL HLDGS are shares owned by insiders. This is 50.0% lower than that of the Healthcare sector and 51.19% lower than that of the Medical Devices industry. The shares owned by insiders for all Germany stocks is 24.78% higher than that of the company.
XTANT MEDICAL HLDGS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XTANT MEDICAL's current stock value. Our valuation model uses many indicators to compare XTANT MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XTANT MEDICAL competition to find correlations between indicators driving XTANT MEDICAL's intrinsic value. More Info.XTANT MEDICAL HLDGS is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XTANT MEDICAL's earnings, one of the primary drivers of an investment's value.XTANT Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses XTANT MEDICAL's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of XTANT MEDICAL could also be used in its relative valuation, which is a method of valuing XTANT MEDICAL by comparing valuation metrics of similar companies.XTANT MEDICAL is currently under evaluation in shares owned by insiders category among its peers.
XTANT Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.0619 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.1) % | |||
| Shares Outstanding | 108.66 M | |||
| Shares Owned By Insiders | 7.59 % | |||
| Shares Owned By Institutions | 75.17 % | |||
| Revenue | 56.67 M | |||
| Gross Profit | 32.49 M | |||
| EBITDA | (4.28 M) | |||
| Net Income | (2.83 M) | |||
| Cash And Equivalents | 20.31 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 17.43 M | |||
| Debt To Equity | 0.51 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 1.79 M | |||
| Earnings Per Share | (0.08) X | |||
| Number Of Employees | 116 | |||
| Beta | 0.63 | |||
| Market Capitalization | 72.54 M | |||
| Z Score | 2.4 |
About XTANT MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XTANT MEDICAL HLDGS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XTANT MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XTANT MEDICAL HLDGS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. XTANT MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.
Currently Active Assets on Macroaxis
Other Information on Investing in XTANT Stock
XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.